{"id":2869,"date":"2021-10-01T12:05:00","date_gmt":"2021-10-01T10:05:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2021\/leserbrief-verursacht-ein-sehr-niedriges-ldl-cholesterin-osteoporose"},"modified":"2022-03-17T14:14:17","modified_gmt":"2022-03-17T13:14:17","slug":"leserbrief-verursacht-ein-sehr-niedriges-ldl-cholesterin-osteoporose","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2021\/leserbrief-verursacht-ein-sehr-niedriges-ldl-cholesterin-osteoporose","title":{"rendered":"Leserbrief: Verursacht ein sehr niedriges LDL-Cholesterin Osteoporose?"},"content":{"rendered":"<p>Frage von Dr. S. aus W.: >> Eine 60-j\u00e4hrige Patientin hatte vor 7 Monaten einen ST-Hebungsinfarkt der Lateralwand. Sie hat zeitnah einen Stent erhalten; die linksventrikul\u00e4re Funktion blieb erhalten. Als kardiovaskul\u00e4re Risikofaktoren wurden ein Gelegenheitsrauchen und ein sehr hoher Lp(a)-Wert diagnostiziert (488 nmol\/l). Die Patientin ist sehr sportlich und leicht \u00fcbergewichtig (BMI: 27 kg\/m2). Ihre [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frage von Dr. S. aus W.: >> Eine 60-j\u00e4hrige Patientin hatte vor 7 Monaten einen ST-Hebungsinfarkt der Lateralwand. Sie hat zeitnah einen Stent erhalten; die linksventrikul\u00e4re Funktion blieb erhalten. Als kardiovaskul\u00e4re Risikofaktoren wurden ein Gelegenheitsrauchen und ein sehr hoher Lp(a)-Wert diagnostiziert (488 nmol\/l). Die Patientin ist sehr sportlich und leicht \u00fcbergewichtig (BMI: 27 kg\/m2). Ihre [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[3086,387,909,395,472,2118,758,1274,451,397,448,5563,449,5558,1556,723,3649,501,1069,1601,3647,3005,1369,1040,393,5559,920,236,246,247,499,5564,455,453,410,1388,244,976,1042,5561,456,5560,1233,19,276,250,2190,3445,5562,256,405,3332,70,1709,922,3313,765,1754,241,243,1384,114,3831,2886,5565,1099,1229,376,1679,1268,443,3203,260,567,328,3783,578,2549,379,5566,1861,906,1097,1736],"class_list":["post-2869","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-acth","tag-anastrozol","tag-aripiprazol","tag-bicalutamid","tag-budesonid","tag-bupropion","tag-carbamazepin","tag-cholesterin","tag-cholesterinsynthese-hemmer","tag-citalopram","tag-colestyramin","tag-cosyntropin","tag-cse-hemmer","tag-cyproteron","tag-dapagliflozin","tag-darunavir","tag-degarelix","tag-dexamethason","tag-donepezil","tag-doxycyclin","tag-eslicarbazepin","tag-etidronsaeure","tag-everolimus","tag-exemestan","tag-fludarabin","tag-fludrocortison","tag-fluoxetin","tag-gabapentin","tag-glukokortikoide","tag-glukokortikosteroide","tag-goserelin","tag-heparine","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-ibandronsaeure","tag-insulin-detemir","tag-kortikosteroide","tag-lenalidomid","tag-letrozol","tag-leuprorelin","tag-lipidsenker","tag-medroxyprogesteron","tag-memantin","tag-methadon","tag-methotrexat","tag-methylprednisolon","tag-mirtazapin","tag-mycophenolat-mofetil","tag-nafarelin","tag-nebenwirkungen","tag-olanzapin","tag-osteopenie","tag-osteoporose","tag-oxcarbazepin","tag-paroxetin","tag-pergolid","tag-phenytoin","tag-pramipexol","tag-prednisolon","tag-prednison","tag-pregabalin","tag-protonenpumpenhemmer","tag-raltegravir","tag-rapamycin","tag-riluzol","tag-risedronsaeure","tag-rivastigmin","tag-ropinirol","tag-schleifendiuretika","tag-sibutramin","tag-statine","tag-tacrolimus","tag-tamoxifen","tag-testosteron","tag-tramadol","tag-valdecoxib","tag-valproat","tag-vareniclin","tag-venlafaxin","tag-vitamin-d2","tag-voriconazol","tag-zaleplon","tag-zoledronsaeure","tag-zolmitriptan"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=2869"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/2869\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=2869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=2869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=2869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}